Target-specific agents imaging ectopic and orthotopic human pancreatic cancer xenografts

Pancreas

Volumn 40, Issue 5, 2011, Pages 689-694

  Wang, Wei ^a   Lin, Jie ^a,b   Guha, Sushovan ^c   Tong, Zhimin ^c   Cameron, Arlin G ^a   Zhang, Fujun ^a,d   Qiu, Xiuchun ^a,e   Zou, Chaoxia ^f   Gao, Xu ^f   Mawad, Michel E ^a   Ke, Shi ^a,g  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF TEXAS   (United States)

^d SUN YAT SEN UNIVERSITY   (China)

^e FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^f HARBIN MEDICAL UNIVERSITY   (China)

^g MS BCM360   (United States)

Author keywords

antibody imaging; matrix metalloproteinase; Near infrared imaging; neutrophil gelatinase associated lipocalin; pancreatic cancer; peptide imaging

Indexed keywords

CONTRAST MEDIUM; MMP PEPTIDE IMAGING AGENT; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY NGAL AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; BINDING AFFINITY; CANCER CELL CULTURE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOSOL; DRUG DISTRIBUTION; DRUG PROTEIN BINDING; DRUG SPECIFICITY; FEMALE; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN TARGETING; SIGNAL NOISE RATIO; TARGET CELL; TUMOR XENOGRAFT;

ACUTE-PHASE PROTEINS; ANIMALS; ANTIBODIES, MONOCLONAL; CELL LINE, TUMOR; FEMALE; HUMANS; LIPOCALINS; MATRIX METALLOPROTEINASES; MICE; MICE, NUDE; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; PANCREATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS; TISSUE DISTRIBUTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR MARKERS, BIOLOGICAL;

EID: 79959812635     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0b013e31821f6b14     Document Type: Article

References (20)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin. 2009;59(4):225-249.
2. Krishna NB, LaBundy JL, Saripalli S, et al. Diagnostic value of EUS-FNA in patients suspected of having pancreatic cancer with a focal lesion on CT scan/MRI but without obstructive jaundice. Pancreas. 2009;38(6):625-630.
3. Gemmel C, Eickhoff A, Helmstadter L, et al. Pancreatic cancer screening: State of the art. Expert Rev Gastroenterol Hepatol. 2009;3(1):89-96.
4. Bander NH. Technology insight: Monoclonal antibody imaging of prostate cancer. Nat Clin Pract Urol. 2006;3(4):216-225.
5. Ghose T, Tai J, Guclu A, et al. Use of cell surface localizing antihepatoma antibody for tumor imaging and therapy with drug-linked antibody. Transplant Proc. 1980;12(1):192-194. (Pubitemid 10061034)
6. WangW, Shao R,Wu Q, et al. Targeting gelatinases with a near-infrared fluorescent cyclic His-Try-Gly-Phe peptide. Mol Imaging Biol. 2009;11(6):424-433.
7. Kjeldsen L, Johnsen AH, Sengelov H, et al. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem. 1993;268(14):10425-10432. (Pubitemid 23150227)
8. Strong RK, Bratt T, Cowland JB, et al. Expression, purification, crystallization and crystallographic characterization of dimeric and monomeric human neutrophil gelatinase associated lipocalin (NGAL). Acta Crystallogr D Biol Crystallogr. 1998;54(Pt 1):93-95. (Pubitemid 28111123)
9. Moniaux N, Chakraborty S, Yalniz M, et al. Early diagnosis of pancreatic cancer: Neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia. Br J Cancer. 2008;98(9):1540-1547. (Pubitemid 351652327)
10. Furutani M, Arii S, Mizumoto M, et al. Identification of a neutrophil gelatinase-associated lipocalin mRNA in human pancreatic cancers using a modified signal sequence trap method. Cancer Lett. 1998;122(1-2):209-214. (Pubitemid 28058638)
11. Argani P, Rosty C, Reiter RE, et al. Discovery of new markers of cancer through serial analysis of gene expression: Prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma. Cancer Res. 2001;61(11):4320-4324. (Pubitemid 32685751)
12. Han H, Bearss DJ, Browne LW, et al. Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray. Cancer Res. 2002;62(10):2890-2896. (Pubitemid 34525776)
13. He Y, Liu XD, Chen ZY, et al. Interaction between cancer cells and stromal fibroblasts is required for activation of the uPAR-uPA-MMP-2 cascade in pancreatic cancer metastasis. Clin Cancer Res. 2007;13(11):3115-3124. (Pubitemid 46944892)
14. Zhang S, He H, Lu W, et al. Tracking intrahepatically transplanted islets labeled with Feridex-polyethyleneimine complex using a clinical 3.0-T magnetic resonance imaging scanner. Pancreas. 2009;38(3):293-302.
15. Juuti A, Lundin J, Nordling S, et al. Epithelial MMP-2 expression correlates with worse prognosis in pancreatic cancer. Oncology. 2006;71(1-2):61-68.
16. Yao X, Ji Y, Zeng M, et al. Solid pseudopapillary tumor of the pancreas: Cross-sectional imaging and pathologic correlation. Pancreas. 2010;39(4):486-491.
17. Tian M, Cui YZ, Song GH, et al. Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patients. BMC Cancer. 2008;8:241.
18. Goldsmith SJ. Receptor imaging: Competitive or complementary to antibody imaginǧ Semin Nucl Med. 1997;27(2):85-93. (Pubitemid 27194756)
19. Adams KE, Ke S, Kwon S, et al. Comparison of visible and near-infrared wavelength-excitable fluorescent dyes for molecular imaging of cancer. J Biomed Opt. 2007;12(2):024017.
20. Ke S, Wen X, Gurfinkel M, et al. Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts. Cancer Res. 2003;63(22):7870-7875. (Pubitemid 37466721)